As of 9:30 AM on the 4th, Celltrion is trading at 265,000 KRW, up 2.32% from the previous day. This marks an 11.58% increase compared to October 22. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net purchased 144,355 shares, while foreigners and institutions have net sold 222,953 shares and net purchased 49,657 shares, respectively.


On November 3, Celltrion was a market topic with the headline "Strong performance due to supplying COVID-19 test kits worth 210 billion KRW to the US."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing